Use of cetuximab (CTX) in first -line therapy of metastatic colorectal cancer (mCRC): Patient characteristics, safety, and effectiveness in the EREBUS cohort

被引：0
|
作者：
Smith, Denis
Rouyer, Magali
Mitry, Emmanuel
Francois, Eric
Monnereau, Alain
Cunha, Antonio Sa
Bignon, Emmanuelle
Le Monies, Alise
Jove, Jeremy
Noize, Pernelle
Moore, Nicholas
Fourrier-Reglat, Annie
机构：
[1] Univ Hosp Bordeaux, Bordeaux, France
[2] Univ V Segalen, Serv Pharmacol, Bordeaux, France
[3] Hop Rene Huguenin, Inst Curie, St Cloud, France
[4] Ctr Antoine Lacassagne, F-06054 Nice, France
[5] Inst Bergonie, Bordeaux, France
[6] Chirurg Digest Hop Haut Leveque, Pessac, France
[7] Univ Bordeaux, Serv Pharmacol, Bordeaux, France
[8] Serv Pharmacol, Bordeaux, France
[9] Univ Victor Segalen, Bordeaux, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14168
引用
收藏
页数：1
相关论文
共 50 条
  • [1] USE OF CETUXIMAB (CTX) IN 1ST-LINE THERAPY OF METASTATIC COLORECTAL CANCER (MCRC): PATIENT CHARACTERISTICS, SAFETY AND EFFECTIVENESS IN THE EREBUS COHORT
    Smith, D.
    Rouyer, M.
    Mitry, E.
    Francois, E.
    Monnereau, A.
    Sa-Cunha, A.
    Jove, J.
    Noize, P.
    Moore, N.
    Fourrier-Reglat, A.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 219 - 219
  • [2] Use of Cetuximab (CTX) in 1st-Line Therapy of Metastatic Colorectal Cancer (mCRC): Patient Characteristics, Safety and Effectiveness in the EREBUS Cohort
    Fourrier-Reglat, Annie
    Smith, Denis
    Rouyer, Magali
    Francois, Eric
    Mitry, Emmanuel
    Monnereau, Alain
    Sa-Cunha, Antonio
    Bignon, Emmanuelle
    Le Monies, Alise
    Lassalle, Regis
    Noize, Pernelle
    Moore, Nicholas
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 458 - 459
  • [3] Effectiveness and Safety of Cetuximab as First-line Treatment in the Elderly with Metastatic Colorectal Cancer from the EREBUS Cohort
    Fourrier-Reglat, Annie
    Noize, Pernelle
    Rouyer, Magali
    Smith, Denis
    Francois, Eric
    Monnereau, Alain
    Balestra, Aurelie
    Jove, Jeremy
    Lassalle, Regis
    Moore, Nicholas
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 310 - 310
  • [4] Effectiveness and Safety of Cetuximab in First-Line Therapy of Metastatic Colorectal Cancer According to Frailty in the EREBUS Study
    Gouverneur, Amandine
    Coutureau, Juliette
    Rouyer, Magali
    Smith, Denis
    Francois, Eric
    Monnereau, Alain
    Balestra, Aurelie
    Jove, Jeremy
    Lassalle, Regis
    Moore, Nicholas
    Fourrier-Reglat, Annie
    Noize, Pernelle
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 520 - 521
  • [5] Surgical resection of metastases and survival outcomes in patients with metastatic colorectal cancer (mCRC) treated with cetuximab (CTX) in the EREBUS cohort of real-life use
    Smith, D.
    Cunha, A. Sa
    Rouyer, M.
    Noize, P.
    Jove, J.
    Bignon, E.
    Monnereau, A.
    Francois, E.
    Mitry, E.
    Fourrier-Reglat, A.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S538 - S538
  • [6] Cetuximab with irinotecan or oxaliplatin for first-line metastatic colorectal cancer: Effectiveness in the EREBUS cohort compared to pivotal trials.
    Fourrier-Reglat, Annie
    Rouyer, Magali
    Noize, Pernelle
    Bignon, Emmanuelle
    Le Monies, Alise
    Jove, Jeremy
    Monnereau, Alain
    Cunha, Antonio Sa
    Francois, Eric
    Mitry, Emmanuel
    Smith, Denis Michel
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [7] NK cells infiltrate in primary tumor influences response to cetuximab (CTX) in first-line therapy of metastatic colorectal cancer (mCRC)
    Marechal, R.
    Nagy, N.
    Verrellen, A.
    Larsimont, D.
    Hendlisz, A.
    Demols, A.
    Demetter, P.
    Van Laethem, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [8] Surgical resection of liver metastases and survival outcomes in real-life for metastatic colorectal cancer (mCRC) patients treated in front-line with cetuximab (CTX): The EREBUS cohort.
    Smith, Denis Michel
    Cunha, Antonio Sa
    Rouyer, Magali
    Noize, Pernelle
    Jove, Jeremy
    Bignon, Emmanuelle
    Le Monies, Alise
    Mitry, Emmanuel
    Francois, Eric
    Fourrier-Reglat, Annie
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [9] Cetuximab with Irinotecan or Oxaliplatin for 1st-Line Metastatic Colorectal Cancer: Effectiveness in the EREBUS Cohort Compared to Pivotal Trials
    Noize, Pernelle
    Fourrier-Reglat, Annie
    Rouyer, Magali
    Grelaud, Angela
    Bignon, Emmanuelle
    de Sagazan, Alise Le Monies
    Lassalle, Regis
    Jove, Jeremy
    Monnereau, Alain
    Cunha, Antonio Sa
    Francois, Eric
    Mitry, Emmanuel
    Moore, Nicholas
    Smith, Denis
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 60 - 61
  • [10] Outcomes of cetuximab in 1st-line therapy for metastatic colorectal cancer (mCRC) according to tumor RAS/BRAF mutation (mt) status in the EREBUS cohort.
    Smith, Denis Michel
    Rouyer, Magali
    Francois, Eric
    Cunha, Antonio Sa
    Monnereau, Alain
    Yon, Edwige
    Bignon, Emmanuelle
    Droz-Perroteau, Cecile
    Noize, Pernelle
    Moore, Nicholas
    Fourrier-Reglat, Annie
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345